Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-15

Clinical Trial Update: A Study in Participants With Moderate to Severe Rheumatoid Arthritis [Phase 3]

View source ↗

Summary

Phase 3 trial update for a rheumatoid arthritis study completed with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eli Lilly and Company | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2017-08-15